跳至主要内容
临床试验/NCT04717219
NCT04717219Unknown不适用

Myeloid Cell Reprogramming in Aortic Valve Stenosis

Radboud University Medical Center3 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2020年11月19日最近更新:
适应症

试验速览

阶段
不适用
入组人数
400
试验地点
3
主要终点
Inflammatory phenotype of circulating immune cells.

研究概览

简要总结

Investigators plan to characterize systemic inflammation and circulating immune cells in participants with moderate and severe calcific aortic valve disease and matched healthy controls.

详细描述

Calcific aortic valve disease (CAVD) is the most common type of valvular heart disease in the Western world. Due to the aging of the population, the impact of this disorder is expected to further increase in the next decades. The underlying pathophysiology remains incompletely defined and there are currently no effective medical treatments capable of altering its course, identifying a major unmet need in this growing population of patients.

Based on the similarities between CAVD and atherosclerosis in pathophysiology and shared risk factors, it is now hypothesized that activation of the innate immune system contributes to the development of CAVD. Therefore, the investigators will perform an observational study to assess the role of activation of the innate immune system in CAVD.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Mild, moderate or severe degenerative aortic valve stenosis as defined by transthoracic echocardiography according to the 2017 ESC/EACTS guidelines for the management of valvular heart disease.

排除标准

  • Active auto-inflammatory or auto-immune diseases
  • Anti-inflammatory drugs
  • Vaccination less than one month before inclusion
  • Bone marrow transplantation
  • Active malignancy, except for local basal cell carcinoma or local squamous cell skin carcinoma, that can be treated curatively by excision.
  • History of endocarditis of the aortic valve
  • History of radiation therapy aimed at the chest
  • Acute ischemic cardiac event less than three months before inclusion
  • Systemic inflammation less than one month before inclusion with fever and/or for which antibiotics have been prescribed, with the exception for the use of nitrofurantoin for a urinary tract infection without fever

结局指标

主要结局

Inflammatory phenotype of circulating immune cells.

时间窗: 2 years

The inflammatory phenotype of circulating immune cells will be measured by determining the cytokine production capacity after stimulation with relevant stimuli.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Niels Riksen

Prof. dr.

Radboud University Medical Center

研究点 (3)

Loading locations...

相似试验